TREATING ULCERATIVE COLITIS WITH BRAZIKUMAB

The disclosure relates to products and methods for treating ulcerative colitis. The products relate to antibodies that inhibit native human IL-23, but do not inhibit IL-12. L'invention concerne des produits et des méthodes de traitement de la rectocolite hémorragique. Les produits concernent de...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GOMMOLL, Carl, SAHOO, Aparna
Format:	Patent
Sprache:	eng ; fre
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	GOMMOLL, Carl SAHOO, Aparna
description	The disclosure relates to products and methods for treating ulcerative colitis. The products relate to antibodies that inhibit native human IL-23, but do not inhibit IL-12. L'invention concerne des produits et des méthodes de traitement de la rectocolite hémorragique. Les produits concernent des anticorps qui inhibent l'IL-23 humaine native, mais n'inhibent pas l'IL-12.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2020012244A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2020012244A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2020012244A23</originalsourceid><addsrcrecordid>eNrjZNAOCXJ1DPH0c1cI9XF2DQIyw1wVnP19PEM8gxXCPUM8FJyCHKM8vUN9HZ14GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakl8uL-RgZGBgaGRkYmJo5ExcaoAH7Ql8w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TREATING ULCERATIVE COLITIS WITH BRAZIKUMAB</title><source>esp@cenet</source><creator>GOMMOLL, Carl ; SAHOO, Aparna</creator><creatorcontrib>GOMMOLL, Carl ; SAHOO, Aparna</creatorcontrib><description>The disclosure relates to products and methods for treating ulcerative colitis. The products relate to antibodies that inhibit native human IL-23, but do not inhibit IL-12. L'invention concerne des produits et des méthodes de traitement de la rectocolite hémorragique. Les produits concernent des anticorps qui inhibent l'IL-23 humaine native, mais n'inhibent pas l'IL-12.</description><language>eng ; fre</language><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200116&DB=EPODOC&CC=WO&NR=2020012244A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200116&DB=EPODOC&CC=WO&NR=2020012244A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GOMMOLL, Carl</creatorcontrib><creatorcontrib>SAHOO, Aparna</creatorcontrib><title>TREATING ULCERATIVE COLITIS WITH BRAZIKUMAB</title><description>The disclosure relates to products and methods for treating ulcerative colitis. The products relate to antibodies that inhibit native human IL-23, but do not inhibit IL-12. L'invention concerne des produits et des méthodes de traitement de la rectocolite hémorragique. Les produits concernent des anticorps qui inhibent l'IL-23 humaine native, mais n'inhibent pas l'IL-12.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAOCXJ1DPH0c1cI9XF2DQIyw1wVnP19PEM8gxXCPUM8FJyCHKM8vUN9HZ14GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakl8uL-RgZGBgaGRkYmJo5ExcaoAH7Ql8w</recordid><startdate>20200116</startdate><enddate>20200116</enddate><creator>GOMMOLL, Carl</creator><creator>SAHOO, Aparna</creator><scope>EVB</scope></search><sort><creationdate>20200116</creationdate><title>TREATING ULCERATIVE COLITIS WITH BRAZIKUMAB</title><author>GOMMOLL, Carl ; SAHOO, Aparna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2020012244A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2020</creationdate><toplevel>online_resources</toplevel><creatorcontrib>GOMMOLL, Carl</creatorcontrib><creatorcontrib>SAHOO, Aparna</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GOMMOLL, Carl</au><au>SAHOO, Aparna</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TREATING ULCERATIVE COLITIS WITH BRAZIKUMAB</title><date>2020-01-16</date><risdate>2020</risdate><abstract>The disclosure relates to products and methods for treating ulcerative colitis. The products relate to antibodies that inhibit native human IL-23, but do not inhibit IL-12. L'invention concerne des produits et des méthodes de traitement de la rectocolite hémorragique. Les produits concernent des anticorps qui inhibent l'IL-23 humaine native, mais n'inhibent pas l'IL-12.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; fre
recordid	cdi_epo_espacenet_WO2020012244A2
source	esp@cenet
title	TREATING ULCERATIVE COLITIS WITH BRAZIKUMAB
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T13%3A30%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GOMMOLL,%20Carl&rft.date=2020-01-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2020012244A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true